Ideally, Medical Affairs organizational design should be assessed early on in Medical Affairs functional development to identify...

In the fast-paced world of life sciences, especially in early-stage cell and gene therapy companies, a tug-of-war exists between...

One of the most pressing challenges pharmaceutical companies face is balancing the need to invest in critical capabilities like...

Medical, Legal, and Regulatory Review Process Emerging life science companies face a unique challenge when it comes to managing...

Consider, for a moment, the measurement of impact that commercial activities and medical affairs activities in a life science...

As a first-time launcher, the ability to quickly identify hurdles and take action through this exciting and turbulent time is...

One of the key learnings from successful product launches is that successful launch teams relentlessly measure performance and...

In the first critical months a biopharmaceutical product is in-market, stakeholders need accessible, reliable information to make...

We’ve been discussing the importance of an emerging biopharma company’s supply chain team in our recent blog series, “Heroes in...

We’ve been discussing the importance of an emerging biopharma company’s supply chain team in our recent blog series, “Heroes in...